Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility

A Daei Sorkhabi, A Sarkesh… - Journal of Basic and …, 2022 - degruyter.com
The recent pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of Coronavirus Disease 2019 (COVID-19) has introduced itself into the …

L-shaped association of serum 25-hydroxyvitamin D with all-cause and cardiovascular mortality in older people with chronic kidney disease: results from the NHANES …

R Li, Y Li, Z Fan, Z Liu, J Lin, M He - BMC public health, 2023 - Springer
Background This study was conducted to assess the association of serum 25-
hydroxyvitamin D [25 (OH) D] concentrations with all-cause and cardiovascular disease …

The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID …

HM AlNafea, AA Korish - Blood Coagulation & Fibrinolysis, 2023 - journals.lww.com
Thromboembolic complications including cerebrovascular accidents, pulmonary embolism,
myocardial infarction, deep vein thrombosis and disseminating intravascular coagulopathy …

Efecto de la administración de diferentes formas de vitamina D en la presión arterial y rigidez aórticas, y su implicación en la reducción de la albuminuria en la …

A Martin-Romero, J Perelló-Martínez… - Clínica e investigación …, 2022 - Elsevier
Antecedentes y objetivos La vitamina D (vitD) ejerce efectos pleiotrópicos como son las
modificaciones de la función arterial y descenso de la albuminuria. Existe 1-alfa-hidroxilasa …

A notable key for estimating the severity of COVID-19: 25-hydroxyvitamin D status

M Ergin Tuncay, E Gemcioglu, B Kayaaslan… - Turkish Journal of …, 2021 - degruyter.com
Background Vitamin D is recognized to be an immune regulator. Also, it is known to have
antiviral effects by several mechanisms, including reducing inflammatory cytokines …